Developing a New LIFU Neuromodulation Method to Suppress Tremor
Run by University of Calgary · NCT07103265 · Data updated 2026-11-12
Not yet open. This study is not taking new participants. Its registered completion date is 2027-07-15.
The investigators aim to apply low intensity focused ultrasound neuromodulation to patients with essential tremor to evaluate the efficacy of this intervention in reducing the amplitude of hand tremor compared to sham stimulation.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Calgary Academic / other |
| Drugs / interventions | Transcranial focused ultrasound stimulation, Sham stimulation |
| Trial ID | NCT07103265 on ClinicalTrials.gov |
What this trial studies
Transcranial ultrasound stimulation is a non-invasive brain stimulation that uses low intensity focused ultrasound (LIFU) to modulate neural activity with high spatial precision (Zadeh et al., 2024). Several human and animal studies have demonstrated that LIFU can produce lasting neuromodulatory effects, including both excitatory and inhibitory responses in the primary motor cortex (Zadeh et al., 2024). Furthermore, evidence suggests that LIFU is capable of inducing plasticity in the human brain that resembles long term potentiation or long-term depression (Zeng et al., 2024). The ability of LIFU to induce bidirectional effects, either excitatory or inhibitory, depending on sonication parameters, offers a level of flexibility in tailoring neuromodulatory interventions to individual patient needs and specific neural circuit dysfunctions. Combined with real-time neuronavigation and acoustic modeling tools, LIFU provides a promising platform for precise, personalized, and non-invasive brain stimulation. The modulatory effect of LIFU depends on sonication parameters such as frequency, attenuation, and pulse repetition frequency (Zeng et al., 2024; Manuel et al., 2020), and evidence from both preclinical and clinical studies suggests these effects can persist beyond the stimulation period consistent with long-term potentiation or long-term depression-like plasticity mechanisms (Fomenko et al., 2020; Zadeh et al., 2024). Unlike other neuromodulatory techniques such as transcranial…
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Diagnosis of Essential Tremor OR Diagnosis of Parkinson's Disease Exclusion Criteria: * Presence of any neurological diagnosis other than Essential Tremor and Parkinson's Disease * Family history of Essential Tremor OR Parkinson's Disease * Inability to undergo MRI or attend to the experimental study sessions
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cerebral oximetry-guided care after cardiac arrest
This study tests whether using a brain oxygen monitor can help guide treatment for adults who have had a cardiac arrest to protect the brain and improve outcomes.
-
What helps choking in babies under age two: a look at real-life interventions
This study tests which choking first aid techniques used by bystanders or providers are safest and most effective for infants under two years old in Alberta, Canada.
-
Choking interventions in adults and children: what works when someone is blocking the airway
This study observes real-world choking events in Alberta to see which bystander or EMS treatments help people who are over 2 years old.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Intra-arterial Thrombolysis After Endovascular Thrombectomy in AIS
This trial tests whether giving intra-arterial thrombolysis with tenecteplase or alteplase after endovascular thrombectomy helps improve recovery in adults with acute ischemic stroke.
-
Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases
This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.